| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Adam H Schechter | President Ceo | 113,137 | 0 | 30 Mar, 2026 |
| Glenn A Eisenberg | Executive Vice President | 37,920 | 0 | 31 Mar, 2025 |
| Brian J Caveney | Evp, Pres Of Ed, Cmo Cso | 36,492 | 0 | 30 Mar, 2026 |
| Lance Berberian | Evp, Special Advisor, Strategy | 18,652 | 0 | 31 Mar, 2025 |
| Jean-Luc Belingard | - | 17,781 | 0 | 08 Feb, 2024 |
| Garheng Kong | - | 13,739 | 0 | 13 Feb, 2026 |
| Paul R Kirchgraber | Ceo, Covance Drug Development | 12,946 | 0 | 23 May, 2023 |
| Mark S Schroeder | Evp, Pres Diagnostics Coo | 12,677 | 0 | 30 Mar, 2026 |
| Kerrii B Anderson | - | 9,563 | 0 | 13 Feb, 2026 |
| R Sanders Williams | - | 8,120 | 0 | 08 Feb, 2024 |
| Amy B. Summy | Evp, Chief Marketing Officer | 7,880 | 0 | 30 Mar, 2026 |
| Bryan T Vaughn | Evp, Diagnostics | 6,746 | 0 | 30 Mar, 2026 |
| Dwight Gary Gilliland | - | 6,656 | 0 | 01 Aug, 2025 |
| Der Vaart Sandra D Van | Evp, Corporate Affairs | 6,239 | 0 | 30 Mar, 2026 |
| Jonathan P. Divincenzo | Evp, Pres, Central Labs Intl | 5,461 | 0 | 29 Mar, 2024 |
| Jeffrey A. Davis | - | 5,460 | 0 | 13 Feb, 2026 |
| Anita Z Graham | Evp, Chro | 5,185 | 0 | 30 Mar, 2026 |
| Akinbolade Oyegunwa | Evp, Cio Cto | 5,064 | 0 | 30 Mar, 2026 |
| Megan D. Bailey | Evp, Pres, Central Labs Intl | 4,851 | 0 | 30 Mar, 2026 |
| Kathryn W Kyle | Evp, Chief Legal Officer | 4,575 | 0 | 30 Mar, 2026 |
| Judith C Seltz | Evp, Chro | 4,182 | 0 | 03 Apr, 2023 |
| Kathryn E Wengel | - | 4,133 | 0 | 13 Feb, 2026 |
| Jonathan C Meltzer | Evp, Operations | 3,620 | 0 | 30 Mar, 2026 |
| Kirsten Marie Kliphouse | - | 3,160 | 0 | 13 Feb, 2026 |
| Paul Rothman | - | 2,571 | 0 | 13 Feb, 2026 |
| Peter J Wilkinson | Svp, Chief Accounting Officer | 1,852 | 0 | 30 Mar, 2026 |
| Julia Aijun Wang | Chief Financial Officer, Evp | 1,817 | 0 | 13 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Mar, 2026 | Akinbolade Oyegunwa | Common Stock | A | 1,340 | $0.00 | 5,446 | D | A |
| 26 Mar, 2026 | Peter J Wilkinson | Common Stock | A | 2,388 | $0.00 | 4,240 | D | A |
| 26 Mar, 2026 | Brian J Caveney | Common Stock | A | 9,304 | $0.00 | 39,411 | D | A |
| 26 Mar, 2026 | Der Vaart Sandra D Van | Common Stock | A | 6,382 | $0.00 | 8,961 | D | A |
| 26 Mar, 2026 | Kathryn W Kyle | Common Stock | A | 1,584 | $0.00 | 5,026 | D | A |
| 26 Mar, 2026 | Mark S Schroeder | Common Stock | A | 9,304 | $0.00 | 15,777 | D | A |
| 26 Mar, 2026 | Adam H Schechter | Common Stock | A | 58,470 | $0.00 | 139,243 | D | A |
| 26 Mar, 2026 | Jonathan C Meltzer | Common Stock | A | 2,388 | $0.00 | 5,170 | D | A |
| 26 Mar, 2026 | Megan D. Bailey | Common Stock | A | 1,184 | $0.00 | 5,332 | D | A |
| 26 Mar, 2026 | Bryan T Vaughn | Common Stock | A | 1,584 | $0.00 | 7,197 | D | A |
| 26 Mar, 2026 | Amy B. Summy | Common Stock | A | 3,994 | $0.00 | 9,716 | D | A |
| 26 Mar, 2026 | Anita Z Graham | Common Stock | A | 6,604 | $0.00 | 8,064 | D | A |
| 26 Mar, 2026 | Bryan T Vaughn | Common Stock | D | 451 | $268.38 | 6,746 | D | F |
| 26 Mar, 2026 | Mark S Schroeder | Common Stock | D | 4,600 | $268.38 | 11,177 | D | F |
| 26 Mar, 2026 | Kathryn W Kyle | Common Stock | D | 451 | $268.38 | 4,575 | D | F |
| 26 Mar, 2026 | Amy B. Summy | Common Stock | D | 1,836 | $268.38 | 7,880 | D | F |
| 26 Mar, 2026 | Anita Z Graham | Common Stock | D | 2,879 | $268.38 | 5,185 | D | F |
| 26 Mar, 2026 | Peter J Wilkinson | Common Stock | D | 755 | $268.38 | 3,485 | D | F |
| 26 Mar, 2026 | Megan D. Bailey | Common Stock | D | 481 | $268.38 | 4,851 | D | F |
| 26 Mar, 2026 | Jonathan C Meltzer | Common Stock | D | 711 | $268.38 | 4,459 | D | F |